Advantage Trust Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91.1K Buy
+709
New +$83K 0.03% 91
2025
Q4
Sell
-200
Closed -$16.8K 164
2025
Q3
$16.8K Sell
200
-350
-64% -$28.8K 0.01% 149
2025
Q2
$43.5K Buy
550
+200
+57% +$15.9K 0.02% 132
2025
Q1
$31.4K Sell
350
-53
-13% -$4.95K 0.02% 119
2024
Q4
$40.1K Buy
403
+53
+15% +$5.46K 0.02% 116
2024
Q3
$39.7K Hold
350
0.03% 111
2024
Q2
$43.3K Hold
350
0.03% 120
2024
Q1
$46.2K Sell
350
-350
-50% -$43.1K 0.03% 115
2023
Q4
$76.3K Buy
+700
New +$72.7K 0.06% 89

Other funds holding MRK

Advantage Trust Company's MRK Position: Q2 2026 in Review

Advantage Trust Company opened a new position in Merck (MRK) in Q2 2026: 709 shares worth $91.1K. The stake represents 0.03% of the portfolio and ranks #91 among its holdings. This is a return to the name: Advantage Trust Company previously reported a position in MRK as recently as Q3 2025.

Advantage Trust Company first reported a position in MRK in Q4 2023 and has held it in 9 quarters since. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Advantage Trust Company held 709 shares of Merck worth $91.1K as of Q2 2026.
  • Merck was a new Advantage Trust Company position in Q2 2026.
  • Merck made up 0.03% of Advantage Trust Company's portfolio in Q2 2026, its #91 holding.
  • Advantage Trust Company first reported a position in Merck in Q4 2023 and has held it in 9 quarters since.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Advantage Trust Company's 13F filing for Q2 2026, filed 17 Jul 2026.